Literature DB >> 19124734

Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells.

Tatjana Banovic1, Kate A Markey, Rachel D Kuns, Stuart D Olver, Neil C Raffelt, Alistair L Don, Mariapia A Degli-Esposti, Christian R Engwerda, Kelli P A MacDonald, Geoffrey R Hill.   

Abstract

The role of Ag presenting cell subsets in graft-versus-host disease (GVHD) remains unclear. We have thus examined the ability of plasmacytoid dendritic cells (pDC) to modulate transplant outcome. Surprisingly, host pDC were exquisitely sensitive to total body irradiation and were depleted before transplantation, thus allowing us to focus on donor pDC [corrected]. The depletion of all pDC from bone marrow grafts resulted in an acceleration of GVHD mortality while the depletion of mature pDC from G-CSF mobilized splenic grafts had no effect. Thus, donor bone marrow pDC, but not mature pDC contained within stem cell grafts attenuate acute GVHD. In the presence of GVHD, donor pDC completely failed to reconstitute although a CD11clow120G8+ precursor DC reconstituted in an exaggerated and transient manner. These cells expressed Flt-3, the macrophage colony stimulating factor receptor and, consistent with a common dendritic cell (DC) precursor, were capable of differentiation into pDC and conventional DC in vivo in the absence of GVHD. These precursors were MHC class II+ and CD80/86+ but lacked CD40, were actively presenting host Ag and inhibited GVHD and T cell proliferation in a contact-dependent fashion. These data demonstrate that GVHD prevents the maturation of pDC and instead promotes the generation of a suppressive precursor DC, further contributing to the state of immune paralysis after transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19124734     DOI: 10.4049/jimmunol.182.2.912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

Authors:  Elizabeth O Stenger; Hēth R Turnquist; Markus Y Mapara; Angus W Thomson
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

2.  Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Authors:  Mohammad S Hossain; David L Jaye; Brian P Pollack; Alton B Farris; Malefa L Tselanyane; Ebenezer David; John D Roback; Andrew T Gewirtz; Edmund K Waller
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

Review 3.  Biology of graft-versus-host responses: recent insights.

Authors:  Kelli P MacDonald; Warren D Shlomchik; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2013-01       Impact factor: 5.742

4.  Kinetics of immune cell reconstitution predict survival in allogeneic bone marrow and G-CSF-mobilized stem cell transplantation.

Authors:  Edmund K Waller; Brent R Logan; Mingwei Fei; Stephanie J Lee; Dennis Confer; Alan Howard; Shanmuganathan Chandrakasan; Claudio Anasetti; Shanelle M Fernando; Cynthia R Giver
Journal:  Blood Adv       Date:  2019-08-13

5.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

Review 6.  Plasmacytoid dendritic cells: no longer an enigma and now key to transplant tolerance?

Authors:  N M Rogers; J S Isenberg; A W Thomson
Journal:  Am J Transplant       Date:  2013-04-25       Impact factor: 8.086

7.  Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.

Authors:  Kazuhiro Mochizuki; Fang Xie; Shan He; Qing Tong; Yongnian Liu; Izumi Mochizuki; Yajun Guo; Koji Kato; Hideo Yagita; Shin Mineishi; Yi Zhang
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

8.  Activation, immune polarization, and graft-versus-leukemia activity of donor T cells are regulated by specific subsets of donor bone marrow antigen-presenting cells in allogeneic hemopoietic stem cell transplantation.

Authors:  Jian-Ming Li; Lauren T Southerland; Ying Lu; Kataryna A Darlak; Cynthia R Giver; Douglas W McMillin; Wayne A C Harris; David L Jaye; Edmund K Waller
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

Authors:  Shun He; Jianhong Chu; Sumithira Vasu; Youcai Deng; Shunzong Yuan; Jianying Zhang; Zhijin Fan; Craig C Hofmeister; Xiaoming He; Henry C Marsh; Steven M Devine; Jianhua Yu
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-21       Impact factor: 5.742

10.  Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.

Authors:  Yuanyuan Tian; Lijun Meng; Ying Wang; Bohan Li; Hongshuang Yu; Yan Zhou; Tien Bui; Ciril Abraham; Alicia Li; Yongping Zhang; Jian Wang; Chenchen Zhao; Shin Mineishi; Stefania Gallucci; David Porter; Elizabeth Hexner; Hong Zheng; Yanyun Zhang; Shaoyan Hu; Yi Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.